Fresenius Medical Care AG & Co. KGaA (FMEA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Fresenius Medical Care AG & Co. KGaA (FMEA) has a cash flow conversion efficiency ratio of 0.016x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€226.89 Million ≈ $265.25 Million USD) by net assets (€14.20 Billion ≈ $16.61 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see FMEA market cap overview for the company's overall valuation and market capitalisation.
Fresenius Medical Care AG & Co. KGaA - Cash Flow Conversion Efficiency Trend (2016–2025)
This chart illustrates how Fresenius Medical Care AG & Co. KGaA's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Fresenius Medical Care AG & Co. KGaA Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Fresenius Medical Care AG & Co. KGaA ranked by their cash flow conversion efficiency. Explore earnings quality score of Fresenius Medical Care AG & Co. KGaA to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Groep Brussel Lambert NV
BR:GBLB
|
0.038x |
|
Harmony Gold Mining Company Limited
F:HAM
|
0.066x |
|
Federal Realty Investment Trust
NYSE:FRT
|
0.094x |
|
King Yuan Electronics Co Ltd
TW:2449
|
0.094x |
|
Konfoong Materials International Co Ltd
SHE:300666
|
0.013x |
|
SG Micro Corp
SHE:300661
|
0.029x |
|
The Siam Cement Public Company Limited
BK:SCC
|
0.012x |
|
Henan Shijia Photons Technology Co Ltd
SHG:688313
|
-0.038x |
Annual Cash Flow Conversion Efficiency for Fresenius Medical Care AG & Co. KGaA (2016–2025)
The table below shows the annual cash flow conversion efficiency of Fresenius Medical Care AG & Co. KGaA from 2016 to 2025. View today's stock price for Fresenius Medical Care AG & Co. KGaA for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €14.28 Billion ≈ $16.70 Billion |
€2.68 Billion ≈ $3.13 Billion |
0.188x | +24.04% |
| 2024-12-31 | €15.77 Billion ≈ $18.44 Billion |
€2.39 Billion ≈ $2.79 Billion |
0.151x | -14.65% |
| 2023-12-31 | €14.83 Billion ≈ $17.33 Billion |
€2.63 Billion ≈ $3.07 Billion |
0.177x | +26.38% |
| 2022-12-31 | €15.45 Billion ≈ $18.06 Billion |
€2.17 Billion ≈ $2.53 Billion |
0.140x | -21.22% |
| 2021-12-31 | €13.98 Billion ≈ $16.34 Billion |
€2.49 Billion ≈ $2.91 Billion |
0.178x | -48.12% |
| 2020-12-31 | €12.33 Billion ≈ $14.42 Billion |
€4.23 Billion ≈ $4.95 Billion |
0.343x | +76.89% |
| 2019-12-31 | €13.23 Billion ≈ $15.46 Billion |
€2.57 Billion ≈ $3.00 Billion |
0.194x | +21.43% |
| 2018-12-31 | €12.90 Billion ≈ $15.08 Billion |
€2.06 Billion ≈ $2.41 Billion |
0.160x | -21.05% |
| 2017-12-31 | €10.83 Billion ≈ $12.66 Billion |
€2.19 Billion ≈ $2.56 Billion |
0.202x | +14.14% |
| 2016-12-31 | €10.89 Billion ≈ $12.74 Billion |
€1.93 Billion ≈ $2.26 Billion |
0.177x | -- |
About Fresenius Medical Care AG & Co. KGaA
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arr… Read more